Li Long
Corporate Officer/Principal en KEZAR LIFE SCIENCES, INC. .
Perfil
Li Long is currently working as Vice President-Immunology Clinical Development at Kezar Life Sciences, Inc. Prior to this, Dr. Long worked as Senior Director-Clinical Development at Principia Biopharma, Inc. Dr. Long holds a doctorate degree from McGill University.
Cargos activos de Li Long
| Empresas | Cargo | Inicio |
|---|---|---|
| KEZAR LIFE SCIENCES, INC. | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Li Long.
| Empresas | Cargo | Fin |
|---|---|---|
| PRINCIPIA BIOPHARMA INC. | Corporate Officer/Principal | - |
Formación de Li Long.
| McGill University | Doctorate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| KEZAR LIFE SCIENCES, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Principia Biopharma, Inc. is a biopharmaceutical company, which engages in designing and developing oral therapies to patients with significant unmet medical needs in immunology and oncology. It operates through Tailored Covalency platform, which enables to develop small molecule inhibitors of enzymes and receptor ligands with potencies and selectivities that rival those of injectable biologics, yet maintain the convenience of a pill. Its product pipeline includes PRN1008, PRN2246, PRN1371, and immunoproteasome inhibitor. The company was founded by Jack Taunton and Richard A. Miller on October 6, 2008 and is headquartered in South San Francisco, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Li Long